FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3028584612> ?p ?o ?g. }

• W3028584612 endingPage "502" @default.
• W3028584612 startingPage "492" @default.
• W3028584612 abstract "We report results from a phase 2, randomized, double-blind, 2-period trial (48 weeks each) of domagrozumab and its open-label extension in patients with Duchenne muscular dystrophy (DMD). Of 120 ambulatory boys (aged 6 to <16 years) with DMD, 80 were treated with multiple ascending doses (5, 20, and 40 mg/kg) of domagrozumab and 40 treated with placebo. The primary endpoints were safety and mean change in 4-stair climb (4SC) time at week 49. Secondary endpoints included other functional tests, pharmacokinetics, and pharmacodynamics. Mean (SD) age was 8.4 (1.7) and 9.3 (2.3) years in domagrozumab- and placebo-treated patients, respectively. Difference in mean (95% CI) change from baseline in 4SC at week 49 for domagrozumab vs placebo was 0.27 (–7.4 to 7.9) seconds (p = 0.94). There were no significant between-group differences in any secondary clinical endpoints. Most patients had ≥1 adverse event in the first 48 weeks; most were mild and not treatment-related. Median serum concentrations of domagrozumab increased with administered dose within each dose level. Non-significant increases in muscle volume were observed in domagrozumab- vs placebo-treated patients. Domagrozumab was generally safe and well tolerated in patients with DMD. Efficacy measures did not support a significant treatment effect.Clinicaltrials.gov identifiers: NCT02310763 and NCT02907619" @default.
• W3028584612 created "2020-05-29" @default.
• W3028584612 creator A5001131087 @default.
• W3028584612 creator A5007427947 @default.
• W3028584612 creator A5012227405 @default.
• W3028584612 creator A5020829434 @default.
• W3028584612 creator A5024414333 @default.
• W3028584612 creator A5030523303 @default.
• W3028584612 creator A5033266587 @default.
• W3028584612 creator A5042269980 @default.
• W3028584612 creator A5046308926 @default.
• W3028584612 creator A5059742070 @default.
• W3028584612 creator A5062032887 @default.
• W3028584612 creator A5063362332 @default.
• W3028584612 creator A5064714121 @default.
• W3028584612 creator A5068041978 @default.
• W3028584612 creator A5069674813 @default.
• W3028584612 creator A5071163954 @default.
• W3028584612 creator A5071781212 @default.
• W3028584612 creator A5078152396 @default.
• W3028584612 creator A5080614978 @default.
• W3028584612 creator A5081817483 @default.
• W3028584612 creator A5085970575 @default.
• W3028584612 creator A5087363192 @default.
• W3028584612 creator A5089234882 @default.
• W3028584612 creator A5089769676 @default.
• W3028584612 date "2020-06-01" @default.
• W3028584612 modified "2023-10-17" @default.
• W3028584612 title "Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy" @default.
• W3028584612 cites W1524530894 @default.
• W3028584612 cites W1951817210 @default.
• W3028584612 cites W1963588710 @default.
• W3028584612 cites W1966161605 @default.
• W3028584612 cites W1966981537 @default.
• W3028584612 cites W1967657836 @default.
• W3028584612 cites W1972813632 @default.
• W3028584612 cites W1977076937 @default.
• W3028584612 cites W1985486836 @default.
• W3028584612 cites W2002936663 @default.
• W3028584612 cites W2005366749 @default.
• W3028584612 cites W2015511652 @default.
• W3028584612 cites W2016615191 @default.
• W3028584612 cites W2025669016 @default.
• W3028584612 cites W2041052974 @default.
• W3028584612 cites W2043862760 @default.
• W3028584612 cites W2053079324 @default.
• W3028584612 cites W2057293159 @default.
• W3028584612 cites W2058459242 @default.
• W3028584612 cites W2083409148 @default.
• W3028584612 cites W2083700023 @default.
• W3028584612 cites W2084480543 @default.
• W3028584612 cites W2086325363 @default.
• W3028584612 cites W2117372474 @default.
• W3028584612 cites W2125078269 @default.
• W3028584612 cites W2128768501 @default.
• W3028584612 cites W2157085976 @default.
• W3028584612 cites W2164481873 @default.
• W3028584612 cites W2277280343 @default.
• W3028584612 cites W2322800034 @default.
• W3028584612 cites W2327656791 @default.
• W3028584612 cites W2424490565 @default.
• W3028584612 cites W2485309500 @default.
• W3028584612 cites W2507871962 @default.
• W3028584612 cites W2518245700 @default.
• W3028584612 cites W2532593119 @default.
• W3028584612 cites W2753097429 @default.
• W3028584612 cites W2766098981 @default.
• W3028584612 cites W2767436720 @default.
• W3028584612 cites W2770028464 @default.
• W3028584612 cites W2770733887 @default.
• W3028584612 cites W2898465212 @default.
• W3028584612 cites W2971943538 @default.
• W3028584612 doi "https://doi.org/10.1016/j.nmd.2020.05.002" @default.
• W3028584612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32522498" @default.
• W3028584612 hasPublicationYear "2020" @default.
• W3028584612 type Work @default.
• W3028584612 sameAs 3028584612 @default.
• W3028584612 citedByCount "37" @default.
• W3028584612 countsByYear W30285846122020 @default.
• W3028584612 countsByYear W30285846122021 @default.
• W3028584612 countsByYear W30285846122022 @default.
• W3028584612 countsByYear W30285846122023 @default.
• W3028584612 crossrefType "journal-article" @default.
• W3028584612 hasAuthorship W3028584612A5001131087 @default.
• W3028584612 hasAuthorship W3028584612A5007427947 @default.
• W3028584612 hasAuthorship W3028584612A5012227405 @default.
• W3028584612 hasAuthorship W3028584612A5020829434 @default.
• W3028584612 hasAuthorship W3028584612A5024414333 @default.
• W3028584612 hasAuthorship W3028584612A5030523303 @default.
• W3028584612 hasAuthorship W3028584612A5033266587 @default.
• W3028584612 hasAuthorship W3028584612A5042269980 @default.
• W3028584612 hasAuthorship W3028584612A5046308926 @default.
• W3028584612 hasAuthorship W3028584612A5059742070 @default.
• W3028584612 hasAuthorship W3028584612A5062032887 @default.
• W3028584612 hasAuthorship W3028584612A5063362332 @default.
• W3028584612 hasAuthorship W3028584612A5064714121 @default.
• W3028584612 hasAuthorship W3028584612A5068041978 @default.
• W3028584612 hasAuthorship W3028584612A5069674813 @default.

• next